![Dawn Schottlandt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dawn Schottlandt
Investor Relations Kontakt bei
GERON CORPORATION
Profil
Dawn Schottlandt is Senior VP-Corporate Affairs & Investor Relations at Geron Corp.
since 2025.
Formerly, Ms. Schottlandt was VP-Investor Relations & Corporate Communications at Chiasma, Inc. from 2019 to 2020 and VP-Investor Relations & Corporate Communications at ArQule, Inc. from 2015 to 2018.
Education includes undergraduate studies at Boston College.
Aktive Positionen von Dawn Schottlandt
| Unternehmen | Position | Beginn |
|---|---|---|
| GERON CORPORATION | Investor Relations Kontakt | 01.10.2025 |
Ehemalige bekannte Positionen von Dawn Schottlandt
| Unternehmen | Position | Ende |
|---|---|---|
| CHIASMA, INC. | Investor Relations Kontakt | 01.07.2020 |
| ARQULE, INC. | Investor Relations Kontakt | 01.01.2018 |
Ausbildung von Dawn Schottlandt
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Chiasma, Inc.
 Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wählen Sie MarketScreener 
